GENinCode’s £17 Million Initial Public Offering

Addleshaw Goddard advised GENinCode. Specialising in cardiovascular disease risk assessment, GENinCode’s products combine genetic and clinical data to risk assess patients and provide doctors with advanced…

This content is for members only.
Join Now
Already a member? Log in here

Author: Giulia Di Palma

This content is for members only.
Join Now
Already a member? Log in here